Update on Tourette Syndrome

Authors

  • Ana Gabriela Hounie Psiquiatra. Doutora em Ciências pela Faculdade de Medicina da Universidade de São Paulo. Coordenadora do Ambulatório de Síndrome de Tourette do HCFMUSP

DOI:

https://doi.org/10.25118/2763-9037.2012.v2.900

Keywords:

tourette syndrome, attention deficit hyperactivity disorder, ADHD, treatment

Abstract

Tourette syndrome has been increasingly diagnosed and treated in primary care and private practices. In clinical practice, we see that most patients receive antipsychotics. This article aims to provide an update on its treatment and show that there are safer therapeutic alternatives, such as clonidine. Typical and atypical antipsychotics can be left as a second choice.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biography

Ana Gabriela Hounie, Psiquiatra. Doutora em Ciências pela Faculdade de Medicina da Universidade de São Paulo. Coordenadora do Ambulatório de Síndrome de Tourette do HCFMUSP

References

Cath DC, Hedderly T, Ludolph AG, Stern JS, Murphy T, Hartmann A, et al European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment. Eur Child Adolesc Psychiatry. 2011 20:155-71. Erratum in: Eur Child Adolesc Psychiatry. 2011 20:377.

Baron-Cohen S, Scahill VL, Izaguirre J, Hornsey H, Robertson MM. The prevalence of Gilles de la Tourette syndrome in children and adolescents with autism: a large scale study. Psychol Med. 1999;29:1151-9.

Altman G, Staley JD, Wener P. Children with Tourette disorder: a follow-up study in adulthood. J Nerv Ment Dis. 2009;197:305-10.

Jankovic J, Gelineau-Kattner R, Davidson A. Tourette’s syndrome in adults. Mov Disord. 2010;25:2171-5

Roessner V, Plessen KJ, Rothenberger A, Ludolph AG, Rizzo R, Skov L, et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry. 2011;20:173-96. Erratum in: Eur Child Adolesc Psychiatry. 2011;20:377.

Hounie AG, Rosario-Campos, Sampaio AS, Alvarenga PG, Diniz, JB, Miguel EC. “Tourette Syndrome: treatment”. In: Marazitti, D. Handbook of Child and Adolescent Psychopharmacology, 1st ed. Healthcare, 2006, p.145-94.

Scahill L, Riddle MA, King RA, Hardin MT, Rasmusson A, Makuch RW, Leckman JF. Fluoxetine has no marked effect on tic symptoms in patients with Tourette’s syndrome: a double-blind placebo-controlled study. J Child Adolesc Psychopharmacol. 1997;7:75-85.

Passos, RBF, López, JRRA. Síndrome de Gilles de la Tourette associada ao transtorno de déficit de atenção com hiperatividade: resposta clínica satisfatória a inibidor seletivo da recaptura de serotonina e metilfenidato. J. bras. psiquiatr., 2010, 59:160-162.

Hauser RA, Zesiewicz TA. Sertraline-induced exacerbation of tics in Tourette’s syndrome. Mov Disord. 1995;10: 682-4.

Kuo SH, Jimenez-Shahed J. Topiramate in treatment of tourette syndrome. Clin Neuropharmacol. 2010; 33:32-4.

Jankovic J, Jimenez-Shahed J, Brown LW. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. J Neurol Neurosurg Psychiatry. 2010 ;81:70-3. Epub 2009 Sep 1.

Marras C, Andrews D, Sime E, Lang AE. Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology, 2001; 56: 605-10. Disponível em: <http://www.ncbi.nlm.nih.gov/pubmed/11245710

Published

2012-10-31

How to Cite

1.
Hounie AG. Update on Tourette Syndrome. Debates Psiquiatr. [Internet]. 2012 Oct. 31 [cited 2026 Aug. 17];2(5):38-43. Available from: https://revistardp.org.br/revista/article/view/900

Issue

Section

Original Articles

Plaudit